Results 221 to 230 of about 3,141,195 (309)

Euthanasia: A Soft Paradigm for Medical Ethics [PDF]

, 1978
McIntyre, Russell L.
core   +1 more source

Medical ethics - Some thoughts

Indian Journal of Ophthalmology, 2000
Nagpal Pran
doaj  

Clinical Characteristics of Parkinsonism in HTLV‐1‐Associated Myelopathy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Human T‐lymphotropic virus type 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is the classic neurological manifestation of HTLV‐1 infection; however, this virus has also been associated with other neurological disorders. Concurrent parkinsonism is relatively rare and presents diagnostic challenges.
Mika Dozono, Satoshi Nozuma, Shota Hirakata, Takashi Yoshida, Daisuke Kodama, Masakazu Tanaka, Eiji Matsuura, Ryuji Kubota, Hiroshi Takashima   +8 more
wiley   +1 more source

Medical Data and Applied Ethics: Part I [PDF]

, 1969
Murphy, Edmond A.
core   +2 more sources

Ethical and social considerations of applying artificial intelligence in healthcare-a two-pronged scoping review. [PDF]

BMC Med Ethics
Ratti E, Morrison M, Jakab I.
europepmc   +1 more source

Erratum to “Inferring Disease Course From Differential Exon Usage in the Wide Titinopathy Spectrum”

Annals of Clinical and Translational Neurology, EarlyView.
wiley   +1 more source

The Comparative Effectiveness and Tolerability of Sphingosine‐1‐Phosphate Receptor Modulators in Patients With Multiple Sclerosis: A Network Meta‐Analysis of Randomized Controlled Trials

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Sphingosine‐1‐phosphate receptor modulators (S1PRM) are used to treat relapsing multiple sclerosis (MS). Each drug has a different S1PR‐subtype selectivity. They target the G‐protein coupled S1P receptors and exert significant immunomodulatory effects, such as preventing the formation of new CNS lesions and the reactivation of pre ...
Faizan Shahzad, Taimoon Rasheed, Momina Riaz Siddiqui, Hamza Hamid, Marwah Bintay Khalid, Haroon Shabbir, Besher Shami, Abdullah, Syed Ijlal Ahmed   +8 more
wiley   +1 more source

Reconsidering Open-Ended Consent for Biospecimen and Health Record Research in the United States and Europe. [PDF]

Ethics Hum Res
Rothstein MA, Rajasekaran P, Dove ES.
europepmc   +1 more source

High‐Efficacy Treatment in Neuromyelitis Optica Specturm Disorder Patients With Seropositive AQP4 Antibodies—A Real‐World Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the effectiveness of high‐efficacy treatments (HET) and low‐efficacy treatments (LET) in NMOSD patients with anti‐aquaporin‐4 antibodies (AQP4‐ab). Methods In this multi‐center study, we analyzed 183 AQP4‐ab seropositive NMOSD patients who received immunosuppressive treatments (IST).
Xiang Li, Binbin Xue, Jia Li, Dewei Xie, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Xu Zhang, Junhui Xia, Jie Lin   +10 more
wiley   +1 more source

Insights Into the Future: Assessing Medical Students' Artificial Intelligence Readiness - A Cross-Sectional Study at Kerman University of Medical Sciences (2022). [PDF]

Health Sci Rep
Rezazadeh H, Mahani AM, Salajegheh M.
europepmc   +1 more source